Insider Trading History of Bay City Capital Management V Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bay City Capital Management V Llc since 2013. The trader's CIK number is 1461543. At the time of the last reporting, Bay City Capital Management V Llc was the 10% Owner of Interleukin Genetics Inc. (stock ticker symbol ILI). Also see all insider trading activities at Interleukin Genetics Inc.

Note that in the past Bay City Capital Management V LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Bay City Capital Management V Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 EPZM 555,555 $4,999,995 0 $0 0 $0
2014 EPZM 0 $0 566,666 $19,613,483 0 $0
2013 EPZM 166,666 $2,499,990 0 $0 0 $0

Yearly summary of insider trading at Interleukin Genetics Inc (ILIU) by Bay City Capital Management V Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ILIU 30,181,086 $2,987,927 0 $0 0 $0
2014 ILIU 26,491,952 $2,649,195 0 $0 0 $0


Insider trading activities at 2 companies by Bay City Capital Management V Llc:

1. Epizyme, Inc. (EPZM)

2. Interleukin Genetics Inc (ILIU)

Table 1. Insider trading of Epizyme, Inc. (EPZM) by Bay City Capital Management V Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-01-12 EPZM Buy 555,555 9.00 4,999,995
2014-08-26 EPZM Sale 200,000 35.14 7,027,800
2014-08-25 EPZM Sale 200,000 35.77 7,153,600
2014-08-22 EPZM Sale 128,000 32.46 4,154,752
2014-08-21 EPZM Sale 38,666 33.03 1,277,331
2013-06-05 EPZM Buy 166,666 15.00 2,499,990

Table 2. Insider trading of Interleukin Genetics Inc (ILIU) by Bay City Capital Management V Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-07-29 ILIU Buy 30,181,086 .10 2,987,927
2014-12-23 ILIU Buy 26,491,952 .10 2,649,195

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bay City Capital Management V Llc (10% Owner of Interleukin Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.